OBJECTIVE: We sought to determine the bidirectional transfer and distribution of vancomycin and telavancin across the dually perfused term human placental lobule. STUDY DESIGN: The technique of dually perfused placental lobule was used in its recirculating mode to determine the maternal to fetal (M→F) (n = 20) and fetal to maternal (n = 18) transfer of each antibiotic, which were coperfused with their radioactive isotopes. The concentrations of drugs were determined by liquid scintillation spectrometry. RESULTS: In the M→F direction, the transfer of vancomycin (9.6 ± 4%) and telavancin (6.5 ± 2%) were low; however, telavancin retention by the perfused lobule was greater than that of vancomycin (P < .01). The normalized transplacental transfer of telavancin across the placental lobule in the fetal to maternal direction was higher than in the M→F direction (P < .01), suggesting the involvement of placental efflux transporters. CONCLUSION: The ex vivo perfusion experiments revealed low transfer of vancomycin and telavancin to the fetal circuit.
OBJECTIVE: We sought to determine the bidirectional transfer and distribution of vancomycin and telavancin across the dually perfused term human placental lobule. STUDY DESIGN: The technique of dually perfused placental lobule was used in its recirculating mode to determine the maternal to fetal (M→F) (n = 20) and fetal to maternal (n = 18) transfer of each antibiotic, which were coperfused with their radioactive isotopes. The concentrations of drugs were determined by liquid scintillation spectrometry. RESULTS: In the M→F direction, the transfer of vancomycin (9.6 ± 4%) and telavancin (6.5 ± 2%) were low; however, telavancin retention by the perfused lobule was greater than that of vancomycin (P < .01). The normalized transplacental transfer of telavancin across the placental lobule in the fetal to maternal direction was higher than in the M→F direction (P < .01), suggesting the involvement of placental efflux transporters. CONCLUSION: The ex vivo perfusion experiments revealed low transfer of vancomycin and telavancin to the fetal circuit.
Authors: Vanessa R Laibl; Jeanne S Sheffield; Scott Roberts; Donald D McIntire; Sylvia Trevino; George D Wendel Journal: Obstet Gynecol Date: 2005-09 Impact factor: 7.661
Authors: Tatiana N Nanovskaya; Ilona A Nekhayeva; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed Journal: Am J Obstet Gynecol Date: 2006-07-05 Impact factor: 8.661
Authors: Sarah J Hemauer; Tatiana N Nanovskaya; Sherif Z Abdel-Rahman; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed Journal: Biochem Pharmacol Date: 2009-11-06 Impact factor: 5.858
Authors: Medha D Joshi; Gwendolyn M Pais; Jack Chang; Khrystyna Hlukhenka; Sean N Avedissian; Anil Gulati; Walter C Prozialeck; Peter C Lamar; Zhong Zhang; Marc H Scheetz; Brooke Griffin Journal: Antimicrob Agents Chemother Date: 2019-09-23 Impact factor: 5.191
Authors: Stefanie Grafmueller; Pius Manser; Liliane Diener; Pierre-André Diener; Xenia Maeder-Althaus; Lionel Maurizi; Wolfram Jochum; Harald F Krug; Tina Buerki-Thurnherr; Ursula von Mandach; Peter Wick Journal: Environ Health Perspect Date: 2015-05-08 Impact factor: 9.031